摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Vancomycin ketone | 249739-76-2

中文名称
——
中文别名
——
英文名称
Vancomycin ketone
英文别名
(1S,2R,18R,19R,22S,25R,28R,40S)-48-[(2S,3R,4S,5S,6R)-3-[(2S,4S,5S,6S)-4-amino-5-hydroxy-4,6-dimethyloxan-2-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-22-(2-amino-2-oxoethyl)-5,15-dichloro-2,18,32,35,37-pentahydroxy-19-[(4-methyl-2-oxopentanoyl)amino]-20,23,26,42,44-pentaoxo-7,13-dioxa-21,24,27,41,43-pentazaoctacyclo[26.14.2.23,6.214,17.18,12.129,33.010,25.034,39]pentaconta-3,5,8(48),9,11,14,16,29(45),30,32,34(39),35,37,46,49-pentadecaene-40-carboxylic acid
Vancomycin ketone化学式
CAS
249739-76-2
化学式
C65H70Cl2N8O25
mdl
——
分子量
1434.22
InChiKey
QUMBSOVNROUGJD-AXKZAMRESA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -2.8
  • 重原子数:
    100
  • 可旋转键数:
    12
  • 环数:
    12.0
  • sp3杂化的碳原子比例:
    0.4
  • 拓扑面积:
    536
  • 氢给体数:
    18
  • 氢受体数:
    26

反应信息

  • 作为反应物:
    描述:
    Vancomycin ketone吡啶盐酸羟胺 作用下, 以 甲醇 为溶剂, 反应 20.0h, 以67%的产率得到(Z)-Vancomycin oxime
    参考文献:
    名称:
    The synthesis and binding of N-terminal derivatives of vancomycin to a bacterial cell wall analogue
    摘要:
    We report the synthesis of novel derivatives of the glycopeptide antibiotic vancomycin, modified at the N-terminus. Binding constants were measured for the association of these derivatives with the tripeptide analogue N,N-diacetyl-L-lysyl-D-alanyl-D-alanine. Replacement of the sp3 centre of the leucine residue of vancomycin with an sp2 centre resulted in weaker binding in all cases. These findings contrast with the relatively strong binding of some of the analogous derivatives previously obtained from ristocetin A. The reduction in the binding affinities of the vancomycin derivatives is attributed to a conformational change in the antibiotic which is not possible in the analogous derivatives of the aglycone of ristocetin.
    DOI:
    10.1039/a903971f
  • 作为产物:
    描述:
    去甲万古霉素 在 acetate buffer 、 copper(II) sulfate乙醛酸 作用下, 以 乙腈 为溶剂, 反应 18.0h, 以81%的产率得到Vancomycin ketone
    参考文献:
    名称:
    The synthesis and binding of N-terminal derivatives of vancomycin to a bacterial cell wall analogue
    摘要:
    We report the synthesis of novel derivatives of the glycopeptide antibiotic vancomycin, modified at the N-terminus. Binding constants were measured for the association of these derivatives with the tripeptide analogue N,N-diacetyl-L-lysyl-D-alanyl-D-alanine. Replacement of the sp3 centre of the leucine residue of vancomycin with an sp2 centre resulted in weaker binding in all cases. These findings contrast with the relatively strong binding of some of the analogous derivatives previously obtained from ristocetin A. The reduction in the binding affinities of the vancomycin derivatives is attributed to a conformational change in the antibiotic which is not possible in the analogous derivatives of the aglycone of ristocetin.
    DOI:
    10.1039/a903971f
点击查看最新优质反应信息

文献信息

  • Attempted introduction of a fourth amide NH into the carboxylate-binding pocket of glycopeptide antibiotics
    作者:Jochen Görlitzer、Thomas F. Gale、Dudley H. Williams
    DOI:10.1039/a906502d
    日期:——
    We report the synthesis of a novel derivative of the glycopeptide antibiotic vancomycin, modified at the N-terminus. This incorporates a fourth amide NH into the antibiotic, at the position which was formerly the N-terminus of the antibiotic-binding pocket. Although this modification gives the potential to form an extra hydrogen bond to the carboxylate anion of the bacterial cell-wall precursor analogue (N,N)-diacetyl-L-lysyl-D-alanyl-D-alanine, the modified antibiotic does not show enhanced binding to this precursor. This lack of enhanced binding is associated with an unfavourable conformational change (relative to the desired conformation) in the antibiotic.
    我们报告了一种新型糖肽抗生素万古霉素生物的合成过程,该衍生物在 N 端进行了修饰。它在抗生素结合袋 N 端位置加入了第四个酰胺 NH。虽然这种修饰有可能与细菌细胞壁前体类似物(N,N)-二乙酰基-L-赖酰-D-丙氨酰-D-丙氨酸羧酸阴离子形成额外的氢键,但修饰后的抗生素与这种前体的结合力并没有增强。这种结合力不强的现象与抗生素的不利构象变化(相对于理想构象)有关。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素(1-6) 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸